Use of Advisory Committees by the Food and Drug Administration: Hearings Before a Subcommittee of the Committee on Government Operations, House of Representatives, Ninety-third Congress, Second Session ...U.S. Government Printing Office, 1976 |
Результаты поиска по книге
Результаты 1 – 5 из 100
Стр.
... regarding Gutta Percha Points__ Curriculum vitae and prepared statement ...... . 51 39-40 23-26 Crout , J. Richard , M.D. , Director , Bureau of Drugs , Food and Drug Administration , Public Health Service , Department cf Health ...
... regarding Gutta Percha Points__ Curriculum vitae and prepared statement ...... . 51 39-40 23-26 Crout , J. Richard , M.D. , Director , Bureau of Drugs , Food and Drug Administration , Public Health Service , Department cf Health ...
Стр. 2
... regarding these drugs to determine whether or not the use of an advisory committee would be appropriate , and whether FDA has been providing adequate health protection to the public . The subcommittee staff has ascertained from FDA ...
... regarding these drugs to determine whether or not the use of an advisory committee would be appropriate , and whether FDA has been providing adequate health protection to the public . The subcommittee staff has ascertained from FDA ...
Стр. 3
... regarding this new dental drug , N2 . Mr. Chairman , I have submitted my curriculum vitae with my pre- pared statement . In order to save time , I am requesting that it be made part of the record . Mr. FOUNTAIN . It will be made a part ...
... regarding this new dental drug , N2 . Mr. Chairman , I have submitted my curriculum vitae with my pre- pared statement . In order to save time , I am requesting that it be made part of the record . Mr. FOUNTAIN . It will be made a part ...
Стр. 5
... regarding the N2 situation . I did this inasmuch as earlier correspondence from various dentists , directed to the Division of Surgical - Dental Drug Products , Office of Scientific Evaluation , Bu- reau of Drugs of FDA , had elicited ...
... regarding the N2 situation . I did this inasmuch as earlier correspondence from various dentists , directed to the Division of Surgical - Dental Drug Products , Office of Scientific Evaluation , Bu- reau of Drugs of FDA , had elicited ...
Стр. 6
... regarding the N2 situation would be Dr. Richard Crout , Director of the Bureau of Drugs . It was further added that if I could not apply political pres- sure or convince Dr. Crout , nothing would be done . Additionally , Dr. Gilkes said ...
... regarding the N2 situation would be Dr. Richard Crout , Director of the Bureau of Drugs . It was further added that if I could not apply political pres- sure or convince Dr. Crout , nothing would be done . Additionally , Dr. Gilkes said ...
Другие издания - Просмотреть все
Часто встречающиеся слова и выражения
adequate advertising agency All-Bran American Dental Association American Endodontic Society appropriate cancer CFSAN Chairman cholesterol claims on food clinical Commissioner concerning CONGRESS THE LIBRARY consensus consumers Cosmetic Act criteria Dental Association dentistry develop diet and health dietary fiber dietary supplements discuss disease document draft Drug Administration endodontists evaluate FDA's Federal Food Federal Register fiber Food and Drug food labeling food products FOUNTAIN Glick gutta percha health claims health-related claims health-related information information on food ingredients intake issue Kellogg Kellogg Company letter to dentist LIBRARY OF CONGRESS manufacturers material memo memorandum messages on food misbranded misleading nutrients nutrition nutrition labeling prevention proposed rule public health messages RC2B recommended referred regulations relationship between diet requirements root canal root canal therapy Sargenti Method saturated fat scientific evidence statement subcommittee substantial technique therapeutic tion total dietary pattern treatment vitamins WEISS WERTS YOUNG
Популярные отрывки
Стр. 4 - Mr. Chairman, and members of the subcommittee, I wish to thank you for the opportunity to appear before you today in support of planning funds for the Eau Galle River flood control project.
Стр. 21 - Secretary's approval, the regulation is then forwarded to the Office of Information and Regulatory Affairs in the Office of Management and Budget (OMB) for review under Executive Order 12291.
Стр. 302 - drug," as used in this Act, shall include all medicines and preparations recognized in the United States Pharmacopoeia or National Formulary for internal or external use, and any substance or mixture of substances intended to be used for the cure, mitigation, or prevention of disease of either man or other animals. The term
Стр. 305 - Any drug (except a new animal drug or an animal feed bearing or containing a new animal drug) the composition of which is such that such drug, as a result of investigations to determine its safety and effectiveness for use under such conditions, has become so recognized, but which has not, otherwise than in such investigations, been used to a material extent or for a material time under such conditions.
Стр. 304 - ... no person shall introduce or deliver for introduc-tion into interstate commerce any...
Стр. 298 - Formulary, or any supplement to any of them ; and (2) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and (3) articles (other than food) intended to affect the structure or any function of the body of man or other animals...
Стр. 298 - drug" means (1) articles recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them ; and (2) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and...
Стр. 298 - ... articles (other than food) intended to affect the structure or any function of the body of man or other animals; and (D) articles intended for use as a component of any articles specified in clause (A), (B), or (C); but does not include devices or their components, parts, or accessories.
Стр. 304 - new drug" means — (1) Any drug the composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety of drugs, as safe for use under the conditions prescribed, recommended, or suggested in the labeling thereof, except that such a drug not so recognized shall not be deemed to be a "new drug...
Стр. 407 - Commissioner Food and Drug Administration 5600 Fishers Lane Rockville, Maryland 20857 Dear Dr.